Literature DB >> 26731479

Indenes and tetralenes analogues attenuates lipopolysaccharide-induced inflammation: An in-vitro and in-vivo study.

Shilpa Mohanty1, Yashveer Gautam2, Anil Kumar Maurya1, Arvind S Negi3, Om Prakash4, Feroz Khan4, Dnyaneshwar Umrao Bawankule5.   

Abstract

In an effort to evaluate novel pharmacological activity of 1-chloro-2-formyl indene and tetralene analogues possessing potential antitubercular and antistaphylococcal agents, we explored its anti-inflammatory potential against lipopolysaccharide(LPS)-induced inflammation using in-vitro and in-vivo bioassay. Synthesized analogues significantly inhibited the production and expression of pro-inflammatory cytokines against LPS-induced inflammation in macrophages isolated from mice. Among all the analogues, TAF-5 (1-Chloro-2-formyl-1-tetralene) exhibited most potent anti-inflammatory activity without any cytotoxic effect. We have further evaluated the therapeutic efficacy and safety of TAF-5 in in-vivo system using LPS-induced sepsis, a systemic inflammation model and acute oral toxicity respectively in mice. Oral administration of TAF-5 inhibited the pro-inflammatory cytokines in serum, attenuated the organs injuries and improved host survival in dose dependent manner. Acute oral toxicity study showed TAF-5 is non-toxic at higher dose in mice. These results suggest the suitability of indene and tetralene analogues as new chemical entities for further investigation towards the management of inflammation related diseases.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Indene; Inflammation; LPS; Macrophage; Mice; Sepsis; Tetralene

Mesh:

Substances:

Year:  2015        PMID: 26731479     DOI: 10.1016/j.cbi.2015.12.005

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  2 in total

1.  A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo.

Authors:  Xiangting Ge; Zhiguo Feng; Tingting Xu; Beibei Wu; Hongjin Chen; Fengli Xu; Lili Fu; Xiaoou Shan; Yuanrong Dai; Yali Zhang; Guang Liang
Journal:  Drug Des Devel Ther       Date:  2016-06-30       Impact factor: 4.162

2.  Inhibition of epidermal growth factor receptor attenuates LPS-induced inflammation and acute lung injury in rats.

Authors:  Xiaoou Shan; Yali Zhang; Hongjin Chen; Lili Dong; Beibei Wu; Tingting Xu; Jie Hu; Zhiguo Liu; Wei Wang; Liqin Wu; Zhiguo Feng; Guang Liang
Journal:  Oncotarget       Date:  2017-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.